ABOUT HUIZHONG

Innovation creates future

About Huizhong
General Search
keyword :

Your present location:Home >> About Huizhong >> Development
Development
  1. 1995-1997:

    Set Sail

    1995,Huizhong animal medicine co.,ltd was founded. In Chinese domestic market,firstly launched important extraction for poultry disease,Gan Kang oral solution.

    1996,In Chinese domestic market, firstly developed animal specific antibiotic Sarafloxacin and its preparations, obtained national second class new veterinary medicine certificate. Huizhong was honored as “ High-tech enterprises in Henan Province” by Science and Technology Department of Henan province.

  2. 1998-1999:

    Weigh Anchor

    1999,In Chinese domestic market,firstly launched control release agent-Xin Qi injection,leading a revolution of Chinese traditional water soluble injection.

  3. 2002-2005:

    Voyage

    2002,Luoyang Pulike Biological Engineering,Co.,ltd was founded.

    2005,Domestic first-class veterinary inactivated vaccine GMP production base and the first domestic GMP lyophilized powder for injection workshop was established at Luoyang National New & High Tech Industry Development Zone. Class A test qualification SPF healthy animal room was built with high standard.

  4. 2006-2008:

    Transcend

    2006,The first domestic provincial veterinary medicine engineering technology research center was built and put into use.
    Won the award of “Enterprises which Leading Technological Innovation and Moving China in Animal Husbandry and Veterinary Medicine”. In the world wide, firstly innovated New castle disease-Infectious bronchitis- Avian influenza (H9N2) triple inactivated vaccine, obtained national new drug certificate and launched on the market.

    2007,Be among one of the first batch designated production companies for porcine high- pathogenic blue ear disease inactivated vaccine (NVDC-JXA1 strain), approved by the Ministry of Agriculture.
    In Chinese domestic market, firstly innovated New castle disease-Infectious bronchitis double inactivated vaccine, and New castle disease-infectious bronchitis- Egg drop syndrome triple inactivated vaccine. Obtained national new veterinary medicine certificate and launched on the market.

    2008,Huizhong Animal medicine co., ltd was rated as “High standard High-Tech Enterprise”. In the world wide, firstly innovated Avian influenza (H9) quadruple inactivated vaccine, obtained national new drug certificate and launched on the market. Animal specific antibiotic- Cefquinome raw material and its preparation was successfully developed and obtained national new veterinary medicine certificate.

  5. 2009-2016:

    Soar

    2009,Pulike successfully developed high efficiency swine fever vaccine.
    New castle disease-Infectious bronchitis- Avian influenza (H9) triple inactivated vaccine was identified as national key new products by Ministry of Science and Technology and other four ministries.
    Qinhuang oral solution and Qinhuang granules won the national third class new drug certificate.
    “Duck virus hepatitis refined egg yolk antibody” won national third class new drug certificate.

    2010,“National Research Center for Veterinary Medicine (NVC)” ceremoniously lay a foundation.
    Pulike domestic first innovated porcine circovirus type 2 vaccine was launched on the market.
    Huizhong trade mark “Huiyu” was rated as well-known brand of Henan province. Chairman Zhang Xuke won the title of “ National outstanding scientific and technological workers”.

    2012,Wu Bangguo, Li Changchun and other national leaders come to Pulike to investigate and survey.
    Principle part of NVC's comprehensive R&D building was completed. Company technology center was identified as state-level enterprise technology center by National Development and Reform Commission, Ministry of Science and Technology and other five ministries.

    2013,Pulike won two international scientific and technological progress award. Principle part of production base of Luoyang Huizhong Biotech Co., Ltd was completed.

    2014,“Porcine circovirus prevention and control technology research and application” won the science and technology second class award of Ministry of Education. Director Tian Kegong won the National scientific and technological progress second class award.
    Huizhong Biotech Co., Ltd passed the GMP inspection of Ministry of Agriculture.

    2015,Pulike company successfully listed and launched on Shanghai Stock Exchange, the stock referred as “Pulike”, stock code”603566”.

    2016,Chinese first New castle disease-Infectious bronchitis-Avian influenza (Re-9 strain) genetic engineering triple inactivated vaccine was ceremoniously launched on the market.
    New castle disease-Infectious bronchitis-Avian influenza quadruple genetic engineering inactivate vaccine obtained new veterinary medicine certificate.

  6. 2017

    Wonderful to continue

    2017,Innovation creates future, Huizhong follows international cutting-edge technology, committed to build industry model, to make greater contribution to the development of animal husbandry.

Email: export@huizhongsy.com.cn Tel: +86 0379-61123578
Add: No.15 Zhenghe Road, Luolong District, Luoyang City, Henan Province
豫ICP备11017935号 TECHNICAL SUPPORT BY YICHANG.300.CN